Search

everythinglearnresearchcommunity

for

Search:↓

Recognizing unusual symptoms can lead to early diagnosis and effective treatment of systemic lupus erythematosus.

A chemical called 5-Bromo-2′-deoxyuridine caused rapid hair loss in mice by killing certain skin cells through a specific cell death pathway.

High amphiregulin in the skin is a bad sign for acute graft-versus-host disease.

Blocking certain proteins on immune cells may help treat alopecia areata.

Hidradenitis suppurativa may be more severe in people with Mediterranean fever gene mutations.

Protein Kinase Cε increases skin sensitivity to UV damage and skin cancer risk.

UVF-dermoscopy is a useful tool for accurately diagnosing types of alopecia, especially in people with lighter skin.

Early intervention is important for limited systemic sclerosis patients due to higher pain and ulceration risks.

Some patients with a type of skin lymphoma can experience a rare, non-scarring hair loss that looks like another hair loss condition but has distinct features.

The case shows how hard it is to tell apart Multiple Autoimmune Syndrome from other similar autoimmune conditions, but correct diagnosis is key for treatment to work.

Early diagnosis and treatment are crucial for skin emergencies and drug reactions.

Genetic defects in the glucocorticoid receptor gene can cause conditions with abnormal sensitivity to stress hormones, and other factors may also affect this sensitivity.

Methotrexate injection site reactions are rare but can be managed by changing injection sites and using topical treatments.

A heart transplant patient developed a skin condition called epidermodysplasia verruciformis after taking immune-suppressing drugs.

β-interferon injections for melanoma can cause excessive hair growth at the injection sites.

Sunscreens with UVA blockers effectively reduce skin fluorescence for several hours.

Etanercept may cause lichen planopilaris, so doctors should be cautious.

UVA damages all hair types, especially permanently waved and colored hair.

Nanoparticles can increase light sensitivity in oil-producing skin glands.

Hair loss in a drug reaction case involved both a common shedding phase and an immune attack on hair follicle stem cells.

Mogamulizumab can cause hair loss and skin rashes.

Skin emergency severity rises with other health issues and affects multiple organs; a new grading system can improve patient care.

ZD1839, a cancer drug, can cause mild skin rashes that are treatable without stopping the medication.

Early diagnosis, stopping the suspected drug, and supportive care are crucial for treating Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.

A new imaging method helps see and study touch nerve endings in mouse skin.

A cat with severe skin issues improved with dexamethasone and cetirizine.

Spanish experts provided guidelines for treating skin side effects in cancer patients on new therapies, stressing early action and teamwork.

Cutaneous lupus erythematosus is a chronic skin disease that can progress to systemic lupus in some cases and requires treatment to prevent recurrences and scarring.